113 related articles for article (PubMed ID: 16076082)
1. Proanthocyanidin from grape seeds enhances anti-tumor effect of doxorubicin both in vitro and in vivo.
Zhang XY; Bai DC; Wu YJ; Li WG; Liu NF
Pharmazie; 2005 Jul; 60(7):533-8. PubMed ID: 16076082
[TBL] [Abstract][Full Text] [Related]
2. Proanthocyanidin from grape seeds enhances doxorubicin-induced antitumor effect and reverses drug resistance in doxorubicin-resistant K562/DOX cells.
Zhang XY; Li WG; Wu YJ; Bai DC; Liu NF
Can J Physiol Pharmacol; 2005 Mar; 83(3):309-18. PubMed ID: 15870845
[TBL] [Abstract][Full Text] [Related]
3. Proanthocyanidin from grape seeds potentiates anti-tumor activity of doxorubicin via immunomodulatory mechanism.
Zhang XY; Li WG; Wu YJ; Zheng TZ; Li W; Qu SY; Liu NF
Int Immunopharmacol; 2005 Jul; 5(7-8):1247-57. PubMed ID: 15914329
[TBL] [Abstract][Full Text] [Related]
4. The antitumor effects of selenium compound Na5SeV5O18.3H20 in K562 cell.
Yang JY; Wang ZR
Arch Pharm Res; 2006 Oct; 29(10):859-65. PubMed ID: 17121180
[TBL] [Abstract][Full Text] [Related]
5. Grape seed proanthocyanidins ameliorate Doxorubicin-induced cardiotoxicity.
Li J; Liu H; Ramachandran S; Waypa GB; Yin JJ; Li CQ; Han M; Huang HH; Sillard WW; Vanden Hoek TL; Shao ZH
Am J Chin Med; 2010; 38(3):569-84. PubMed ID: 20503473
[TBL] [Abstract][Full Text] [Related]
6. Anti-osteosarcoma effects and mechanisms of 4-O-amino-phenol-4'-demethylepipodophyllotoxin ether.
Yang TM; Guo SF; Chen CR; Zhang XY; Li WG
J Pharm Pharmacol; 2008 Feb; 60(2):179-88. PubMed ID: 18237465
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of doxorubicin-induced myocardial oxidative stress and immunosuppression by grape seed proanthocyanidins in tumour-bearing mice.
Zhang XY; Li WG; Wu YJ; Gao MT
J Pharm Pharmacol; 2005 Aug; 57(8):1043-52. PubMed ID: 16102261
[TBL] [Abstract][Full Text] [Related]
8. Synergistic anti-cancer effects of grape seed extract and conventional cytotoxic agent doxorubicin against human breast carcinoma cells.
Sharma G; Tyagi AK; Singh RP; Chan DC; Agarwal R
Breast Cancer Res Treat; 2004 May; 85(1):1-12. PubMed ID: 15039593
[TBL] [Abstract][Full Text] [Related]
9. Effect of lutein and doxorubicin combinatorial therapy on S180 cell proliferation and tumor growth.
Luan RL; Wang PC; Yan MX; Chen J
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1514-1520. PubMed ID: 29565515
[TBL] [Abstract][Full Text] [Related]
10. Redifferentiation of human hepatoma cell induced by 6-(p-chlorophenyl)-3-[1-(p-chlorophenyl)-5-methyl-1 H-1,2,3-triazol-4-yl]-s-triazolo[3,4-b]-1,3,4-thiadiazole (TDZ).
Zhang Q; Pan J; Zheng RL; Wang Q
Pharmazie; 2005 May; 60(5):378-82. PubMed ID: 15918590
[TBL] [Abstract][Full Text] [Related]
11. The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells.
Shen J; Zhang W; Wu J; Zhu Y
Int J Hyperthermia; 2008 Mar; 24(2):151-9. PubMed ID: 18283591
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
13. [Small interfering RNA targeting STAT3 enhances antitumor activity of doxorubicin].
Wang TX; Wang YY; Zhang ZQ
Yao Xue Xue Bao; 2013 Jan; 48(1):52-8. PubMed ID: 23600141
[TBL] [Abstract][Full Text] [Related]
14. Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Ji BS; He L; Liu GQ
Life Sci; 2005 Sep; 77(18):2221-32. PubMed ID: 15967469
[TBL] [Abstract][Full Text] [Related]
15. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
16. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer.
Liang G; Tang A; Lin X; Li L; Zhang S; Huang Z; Tang H; Li QQ
Int J Oncol; 2010 Jul; 37(1):111-23. PubMed ID: 20514403
[TBL] [Abstract][Full Text] [Related]
17. Preparation of DOX/BSANP and its antitumor effect on bel-7404 liver cancer cells in vitro and in vivo.
Miao FQ; An YL; Yang R; Tang QS; Zhang JQ
Biomed Mater Eng; 2014; 24(1):599-607. PubMed ID: 24211944
[TBL] [Abstract][Full Text] [Related]
18. Antioxidative and antitumor activity of derivatives of 4-beta-amino-4'-demethylepipodophyllotoxin and their structure-activity relationship.
Zhang XY; Li WG; Wu YJ; Tian X
Pharmazie; 2007 Jun; 62(6):432-8. PubMed ID: 17663190
[TBL] [Abstract][Full Text] [Related]
19. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Xu HB; Li L; Liu GQ
Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
[TBL] [Abstract][Full Text] [Related]
20. [Effects of bufalin combined with doxorubicin on the proliferation and apoptosis of human lung cancer cell line A549 in vitro].
Zhang C; Fu L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 42(7):762-768. PubMed ID: 28844998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
